top of page

Core Systems
Institute
Pricing Plans
Publications
- Press Release
- Past Press Releases
Vision
More

Use tab to navigate through the menu items.

CYNAERA

The Human Variable

All Posts
Business Insights
Healthcare Innovations
Philanthropic Tools
AI Strategy
Public Infrastructure
Data Ethics
Public Policy
White Paper

Search

A Nobel-Scale Advance: AI-Powered CRISPR Platform to End Infection-Associated Chronic Conditions - Lite

A Nobel-Scale Advance: AI-Powered CRISPR Platform to End Infection-Associated Chronic Conditions - Lite

A Nobel-Scale Advance: AI-Powered CRISPR Platform to End Infection-Associated Chronic Conditions - Lite

A Nobel-scale leap, built outside the system. This isn’t just another CRISPR project. CYNAERA’s AI-powered gene editing platform was designed by a patient, for patients—modeling remission across millions of synthetic profiles to restore immune stability in infection-associated chronic conditions like Long COVID, ME/CFS, and MCAS. It cuts years off clinical trial timelines. It eliminates $5–10 million in early development costs. It’s scalable and ethical globally. AI meets bio

May 8

AI That Sees the Whole Picture: Tracking Symptoms and Consequences

AI That Sees the Whole Picture: Tracking Symptoms and Consequences

AI That Sees the Whole Picture: Tracking Symptoms and Consequences

As AI technology continues to revolutionize healthcare, one crucial aspect that cannot be overlooked is data privacy and security.

Healthcare Innovations

Apr 11

Modular AI dashboard with data graphs on dark background.

Modular AI dashboard with data graphs on dark background.

The Hidden Cost of Default Logic: Why Most Systems Fail Before They Start

Default Logic is the baked-in code, policy, or logic that treats outdated context as static truth. A wrong assumption that costs real money.

Business Insights

Apr 8

Subscribe to our newsletter • Don’t miss out!

Email*

I want to subscribe to your mailing list.

CYNAERA

AI systems intelligence for adaptive technology, precision infrastructure, and institutional foresight.

CYNAERA is a Virginia, USA - based LLC registered in Montana

Bioadaptive Systems Therapeutics™ (BST) and affiliated frameworks are proprietary systems by Cynthia Adinig, licensed exclusively to CYNAERA™ for commercialization and research integration. U.S. Provisional Patent Application No. 63/909,951 – Patent Pending. All rights reserved. © 2025 Cynthia Adinig.

bottom of page